About the Cancer Vaccines and Immune Modulation Session
Cancer vaccines and immune modulation represent groundbreaking advances in oncology. Therapeutic vaccines aim to stimulate the immune system to recognize and attack cancer cells, while prophylactic vaccines, like those against HPV, prevent infection-associated cancers. Immune modulation, involving checkpoint inhibitors and adoptive cell therapies, enhances the body’s natural defense mechanisms against tumors. These approaches have shown remarkable success in treating certain cancers, such as melanoma and lung cancer. Continued research in immunotherapy is expanding its applicability to a broader range of malignancies, offering new hope for patients worldwide.
Topics Covered in Cancer Vaccines and Immune Modulation
Therapeutic Vaccines
Prophylactic HPV Vaccines
Neoantigen Targeting
Checkpoint Blockade
Adoptive Cell Therapy
Cytokine Therapy
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Vaccines and Immune Modulation Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Vaccines and Immune Modulation work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Vaccines and Immune Modulation research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Vaccines and Immune Modulation track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Vaccines and Immune Modulation Conference 2027 — FAQs
What is the Cancer Vaccines and Immune Modulation track at CIOC 2027?
The Cancer Vaccines and Immune Modulation track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Vaccines and Immune Modulation. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Vaccines and Immune Modulation sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Vaccines and Immune Modulation are all welcome — whether presenting or attending.
Can I present my research in the Cancer Vaccines and Immune Modulation track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Vaccines and Immune Modulation sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Vaccines and Immune Modulation track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.